Professor Prasanna Sooriakumaran will discuss ‘The PRESIDENT trial: An HTA-funded multi-centre UK full randomised controlled trial of surgery plus current best care versus current best care alone in men diagnosed with low volume metastatic hormone sensitive prostate cancer using novel molecular imaging with PSMA PET/CT.’

Prasanna Sooriakumaran, known as PS, is a Consultant Urological Surgeon at University College London Hospitals NHS Foundation Trust where he performs many of the unit’s complex and salvage robotic prostatectomy surgery, having been robotically trained at Cornell University, the Karolinska Institute, and Oxford University Hospitals. He holds visiting professorships in urology at Oxford and the All-India Institute of Medical Sciences where he is also a visiting professor in robotic surgery. PS also clinically led the National Institute for Health and Care Excellence (NICE)’s early value assessment of robotic soft-tissue surgery in the UK. He has been interested in the topic of surgery for metastatic prostate cancer for over a decade and has conducted many observational studies as well as the world’s first feasibility randomised controlled trial (RCT) in the field, the latter run by NDS. He has recently been funded for £3 million by the HTA as the Chief Investigator on a multi-centre full UK-wide RCT of surgery in metastatic prostate cancer, which will also be run by NDS.

The Chief Medical Officer has confirmed that attendance at the Surgical Grand Rounds can count toward internal CPD, with 1 point awarded per hour. Please note that in-person attendance is required, and you will need to sign the attendance register.

All members of the University and NHS clinical staff are welcome.

Please email Tarryn Ching (tarryn.ching@nds.ox.ac.uk) if you would like to attend online.